This site is intended for healthcare professionals only


ILD series part 3: treatment options and considerations

Posted on: 5 Nov 2019

This video will focus on the treatment options and considerations in interstitial lung disease.

  • Identify treatment options for inflammatory-type ILD
  • Understand the different treatment considerations for inflammatory and fibrotic forms of ILD
  • Identify non-drug treatments and other therapies for ILD

In addition to the video we have a number of downloadable materials for you to download and share with your colleagues – just click on the tabs and the materials will be downloaded automatically:

  • Video feedback form – Your feedback is very important to us and will help to improve our educational videos – please email:
  • Reflective learning log – this log will help you monitor what you have learned in your continuing professional development
  • Video slides – these slides can be used to train other colleagues around treatment options and considerations of ILD
  • Video transcript

If you have any feedback or comments, please email:

Please note that the RCN cannot confirm the competence of any practitioner.

Download: Video evaluation form Download: Reflective learning log Download: Video transcription Download: Video slides - Treatment options and considerations

Other videos in this series

Author: Boehringer Ingelheim
ILD series part 1: identification and patient referral
CPD points
13min 11sec
Author: Boehringer Ingelheim
ILD series part 2: diagnosis and testing
CPD points
13min 44sec
Author: Boehringer Ingelheim
ILD series part 4: end of life care
CPD points
08min 48sec
Author: Circassia
Implementing FeNO testing in primary care: successes and lessons
CPD points
24min 51sec

Media partners

The Primary Care Respiratory Academy has been developed and is produced by Cogora, the publisher of Pulse, Nursing in Practice, Healthcare Leader, Management in Practice and The Pharmacist working in partnership with PCRS. All educational content for the website and Roadshows, unless specified as sponsored content, has been initiated and produced by PCRS/Cogora.